drugset / Trial / NCT07040865

Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings

NCT07040865

Phase 4 Recruiting 104 enrolled Insel Gruppe AG, University Hospital Bern
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The purpose of this study is to compare the effects of the contrast agent Gadopiclenol with those of the standard contrast agent Gadobutrol. The main question of this study is : Does gadopiclenol offer diagnostic properties that are equally effective as those of gadobutrol? Participants will be: * randomly assigned to one of two groups: the experimental group, which receives gadopiclenol, or the control group, which receives gadobutrol. Each participant is informed of their group allocation prior to the magnetic resonance imaging (MRI) scan. * invited for a single MRI appointment lasting approximately 60 minutes

Timeline

Start
2025-08-18
Primary completion
2027-06-30
Completion
2027-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gadobutrol Diagnostic / imaging agent 0.1 unknown Intravenous
Subject Gadopiclenol Diagnostic / imaging agent 0.05 unknown Intravenous

Indications

No indication recorded.